FDA Inspection
Signature Formulations, LLCSignature Formulations, LLC – FDA Inspection, Sep 30, 2021
Record Details
This FDA Inspection record concerns Signature Formulations, LLC, with an inspection on September 30, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Signature Formulations, LLC
- Inspection Date
- September 30, 2021
- Product Type
- Drugs
View Company Profile
ID · 4a4bb511-7742-4277-ab67-4db100404d2c
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1153339
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
7- 21 CFR 211.100(b)Procedure Deviations Recorded and Justified
- 21 CFR 211.198(a)Complaint Handling Procedure
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.160(a)Lab controls established, including changes
- 21 CFR 211.100(a)Absence of Written Procedures
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.166(a)Written program not followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Signature Formulations, LLC
4| Date | Classification | Office | Project area |
|---|---|---|---|
| July 29, 2025 | Not classified | Denver District Office | Drug Quality Assurance |
| November 22, 2023 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 19, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 9, 2017 | Not classified | Denver District Office | Drug Quality Assurance |
Other documents for Signature Formulations, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.